Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model

Critical limb ischemia (CLI) is one of the most severe forms of peripheral artery diseases, but current treatment strategies do not guarantee complete recovery of vascular blood flow or reduce the risk of mortality. Recently, human bone marrow derived mesenchymal stem cells (MSCs) have been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Woong Chol, Oh, Pyung Chun, Lee, Kyounghoon, Ahn, Taehoon, Byun, Kyunghee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106400/
https://www.ncbi.nlm.nih.gov/pubmed/27847443
http://dx.doi.org/10.4196/kjpp.2016.20.6.657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106400/
https://www.ncbi.nlm.nih.gov/pubmed/27847443
http://dx.doi.org/10.4196/kjpp.2016.20.6.657

Ejemplares similares